Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Protein receptor-independent plasma membrane remodeling by HAMLET : a tumoricidal protein-lipid complex. / Nadeem, Aftab; Sanborn, Jeremy; Gettel, Douglas L.; Ho C.S., James; Rydström, Anna; Ngassam, Viviane N.; Klausen, Thomas Kjær; Pedersen, Stine Helene Falsig; Lam, Matti; Parikh, Atul N.; Svanborg, Catharina.

In: Scientific Reports, Vol. 5, 16432, 2015.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nadeem, A, Sanborn, J, Gettel, DL, Ho C.S., J, Rydström, A, Ngassam, VN, Klausen, TK, Pedersen, SHF, Lam, M, Parikh, AN & Svanborg, C 2015, 'Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex', Scientific Reports, vol. 5, 16432. https://doi.org/10.1038/srep16432

APA

Nadeem, A., Sanborn, J., Gettel, D. L., Ho C.S., J., Rydström, A., Ngassam, V. N., Klausen, T. K., Pedersen, S. H. F., Lam, M., Parikh, A. N., & Svanborg, C. (2015). Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex. Scientific Reports, 5, [16432]. https://doi.org/10.1038/srep16432

Vancouver

Nadeem A, Sanborn J, Gettel DL, Ho C.S. J, Rydström A, Ngassam VN et al. Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex. Scientific Reports. 2015;5. 16432. https://doi.org/10.1038/srep16432

Author

Nadeem, Aftab ; Sanborn, Jeremy ; Gettel, Douglas L. ; Ho C.S., James ; Rydström, Anna ; Ngassam, Viviane N. ; Klausen, Thomas Kjær ; Pedersen, Stine Helene Falsig ; Lam, Matti ; Parikh, Atul N. ; Svanborg, Catharina. / Protein receptor-independent plasma membrane remodeling by HAMLET : a tumoricidal protein-lipid complex. In: Scientific Reports. 2015 ; Vol. 5.

Bibtex

@article{4622294d6eb5415e9b509ce9455b163a,
title = "Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex",
abstract = "A central tenet of signal transduction in eukaryotic cells is that extra-cellular ligands activate specific cell surface receptors, which orchestrate downstream responses. This {"}protein-centric{"} view is increasingly challenged by evidence for the involvement of specialized membrane domains in signal transduction. Here, we propose that membrane perturbation may serve as an alternative mechanism to activate a conserved cell-death program in cancer cells. This view emerges from the extraordinary manner in which HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) kills a wide range of tumor cells in vitro and demonstrates therapeutic efficacy and selectivity in cancer models and clinical studies. We identify a {"}receptor independent{"} transformation of vesicular motifs in model membranes, which is paralleled by gross remodeling of tumor cell membranes. Furthermore, we find that HAMLET accumulates within these de novo membrane conformations and define membrane blebs as cellular compartments for direct interactions of HAMLET with essential target proteins such as the Ras family of GTPases. Finally, we demonstrate lower sensitivity of healthy cell membranes to HAMLET challenge. These features suggest that HAMLET-induced curvature-dependent membrane conformations serve as surrogate receptors for initiating signal transduction cascades, ultimately leading to cell death.",
author = "Aftab Nadeem and Jeremy Sanborn and Gettel, {Douglas L.} and {Ho C.S.}, James and Anna Rydstr{\"o}m and Ngassam, {Viviane N.} and Klausen, {Thomas Kj{\ae}r} and Pedersen, {Stine Helene Falsig} and Matti Lam and Parikh, {Atul N.} and Catharina Svanborg",
year = "2015",
doi = "10.1038/srep16432",
language = "English",
volume = "5",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - Protein receptor-independent plasma membrane remodeling by HAMLET

T2 - a tumoricidal protein-lipid complex

AU - Nadeem, Aftab

AU - Sanborn, Jeremy

AU - Gettel, Douglas L.

AU - Ho C.S., James

AU - Rydström, Anna

AU - Ngassam, Viviane N.

AU - Klausen, Thomas Kjær

AU - Pedersen, Stine Helene Falsig

AU - Lam, Matti

AU - Parikh, Atul N.

AU - Svanborg, Catharina

PY - 2015

Y1 - 2015

N2 - A central tenet of signal transduction in eukaryotic cells is that extra-cellular ligands activate specific cell surface receptors, which orchestrate downstream responses. This "protein-centric" view is increasingly challenged by evidence for the involvement of specialized membrane domains in signal transduction. Here, we propose that membrane perturbation may serve as an alternative mechanism to activate a conserved cell-death program in cancer cells. This view emerges from the extraordinary manner in which HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) kills a wide range of tumor cells in vitro and demonstrates therapeutic efficacy and selectivity in cancer models and clinical studies. We identify a "receptor independent" transformation of vesicular motifs in model membranes, which is paralleled by gross remodeling of tumor cell membranes. Furthermore, we find that HAMLET accumulates within these de novo membrane conformations and define membrane blebs as cellular compartments for direct interactions of HAMLET with essential target proteins such as the Ras family of GTPases. Finally, we demonstrate lower sensitivity of healthy cell membranes to HAMLET challenge. These features suggest that HAMLET-induced curvature-dependent membrane conformations serve as surrogate receptors for initiating signal transduction cascades, ultimately leading to cell death.

AB - A central tenet of signal transduction in eukaryotic cells is that extra-cellular ligands activate specific cell surface receptors, which orchestrate downstream responses. This "protein-centric" view is increasingly challenged by evidence for the involvement of specialized membrane domains in signal transduction. Here, we propose that membrane perturbation may serve as an alternative mechanism to activate a conserved cell-death program in cancer cells. This view emerges from the extraordinary manner in which HAMLET (Human Alpha-lactalbumin Made LEthal to Tumor cells) kills a wide range of tumor cells in vitro and demonstrates therapeutic efficacy and selectivity in cancer models and clinical studies. We identify a "receptor independent" transformation of vesicular motifs in model membranes, which is paralleled by gross remodeling of tumor cell membranes. Furthermore, we find that HAMLET accumulates within these de novo membrane conformations and define membrane blebs as cellular compartments for direct interactions of HAMLET with essential target proteins such as the Ras family of GTPases. Finally, we demonstrate lower sensitivity of healthy cell membranes to HAMLET challenge. These features suggest that HAMLET-induced curvature-dependent membrane conformations serve as surrogate receptors for initiating signal transduction cascades, ultimately leading to cell death.

U2 - 10.1038/srep16432

DO - 10.1038/srep16432

M3 - Journal article

C2 - 26561036

AN - SCOPUS:84946943832

VL - 5

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 16432

ER -

ID: 154219760